Catalyst Wire Dossier Catalyst Wire Dossier

HSY244

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HSY244, covering 2023-07-25 to 2023-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation [Phase 2]

See pricing